InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,618.26
(
-0.29%
)
US TECH 100
19,022.00
(
0.44%
)
Dow Jones
41,503.10
(
-0.25%
)
Brent Oil
73.69
(
1.81%
)
Bitcoin
61,972.31
(
0.49%
)
Post# of 1990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

JJCook

Send PM Follow Ignore
Followers 5
Posts 179
Boards Moderated 0
Alias Born 11/19/2017

JJCook

Re: TheShadow post# 1144

Friday, 12/01/2017 12:51:49 PM

Friday, December 01, 2017 12:51:49 PM

Post# of 1990
"The FDA agreed with the Company's decision to continue the ADAPT trial, and further agreed to review a protocol amendment to extend the trial beyond the originally targeted 290 events and a revised statistical analysis plan that the Company plans to submit."

Do we know if the company has submitted that plan yet?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up